Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aduhelm (aducanumab)
Payers
Medicare Part B premiums to decline due to low Aduhelm use
The monthly Medicare Part B premium will decline slightly in 2023 thanks in part to lower-than-expected use of the price drug Aduhelm.
Robert King
Sep 27, 2022 11:51am
Industry Voices—Medicare decision on Aduhelm stifles innovation
Jun 6, 2022 7:00am
CMS will lower Medicare premiums in 2023 to make up for Aduhelm
May 27, 2022 4:34pm